title: The effect of lubricants on powder flowability for pharmaceutical application.
abstract: Pharmaceutical tablets are manufactured through a series of batch steps finishing with compression into a form using a tablet press. Lubricants are added to the powder mixture prior to the tabletting step to ensure that the tablet is ejected properly from the press. The addition of lubricants also affects tablet properties and can affect the behavior of the powder mixture. The objective of this research was to investigate the effect of lubricants on powder flowability as flowability into the tablet press is critical. Four lubricants (magnesium stearate, magnesium silicate, stearic acid, and calcium stearate) were mixed, in varying amounts, with spray-dried lactose. In addition, magnesium stearate was also mixed with placebo granules from a high-shear granulator. Measurements based on avalanche behavior indicated flowability potential and dynamic density and were more sensitive to changes in the mixture and provided a more accurate and reproducible indication of flowability than traditional static measurements. Of the tested lubricants, magnesium stearate provided the best increase in flowability even in the low amounts commonly added in formulations.
authors.affiliation: Biomedical Engineering Graduate Program, The University of Western Ontario, London, N6A 5B9, Canada.
authors.forename: Garett
authors.initials: G
authors.lastname: Morin
authors.forename: Lauren
authors.initials: L
authors.lastname: Briens
mesh_terms: D002626:Chemistry, Pharmaceutical; D054327:Lubricants / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D011208:Powders; D013607:Tablets
chemical_list: D054327:Lubricants; D011208:Powders; D013607:Tablets
references.citation: J Pharm Pharmacol. 1985 Oct;37(10):681-5
references.pmid: 2867134
references.citation: J Pharm Sci. 2010 Feb;99(2):958-68
references.pmid: 19653280
references.citation: Eur J Pharm Biopharm. 2010 May;75(1):1-15
references.pmid: 20096779
references.citation: Int J Pharm. 2007 May 24;336(2):338-45
references.pmid: 17289312
references.citation: Int J Pharm. 2008 Oct 1;362(1-2):109-17
references.pmid: 18652883
references.citation: Drug Dev Ind Pharm. 2003 Mar;29(3):277-87
references.pmid: 12741609
references.citation: Pharmazie. 1975 Jun;30(6):378-82
references.pmid: 169527
references.citation: Acta Pharm Suec. 1985;22(6):343-50
references.pmid: 3832785
references.citation: Int J Pharm. 2004 Aug 6;280(1-2):77-93
references.pmid: 15265549
references.citation: Drug Dev Ind Pharm. 2009 Dec;35(12):1460-9
references.pmid: 19929205
references.citation: Eur J Pharm Biopharm. 2010 Feb;74(2):388-96
references.pmid: 19796683